TITLE

Indian Pharma: Ibuprofen-Plus

AUTHOR(S)
Dinakar, S.
PUB. DATE
February 2006
SOURCE
Forbes Asia;2/27/2006, Vol. 2 Issue 3, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the decision of Shasun Chemicals & Drugs of India to delay its plans for a plant in Thailand that would supply raw materials for manufacturing the painkiller Ibuprofen in May 2005. The company purchased contract development company Chirex from Rhodia in 2000. Shasun expects that its two British factories making patented drugs for customers such as Eli Lilly and GlaxoSmith line will give it a strong position in the U.S. and European market. Shasun is still planning to build its own plant for Ibuprofen despite diversifying.
ACCESSION #
20992621

 

Related Articles

  • Shasun Chemicals to diversify into textiles.  // Colourage;Jul95, Vol. 42 Issue 7, p69 

    Reports on the diversification of Shasun Chemicals and Drugs Ltd. by setting up of a textile spinning unit. Manufacture of cotton and cotton-viscose blended yarn.

  • ChiRex acquiring Glaxo drug plant in contract move. Lerner, Matthew // Chemical Market Reporter;07/14/97, Vol. 252 Issue 2, p1 

    Focuses on ChiRex Inc.'s letter of intent to acquire Glaxo Wellcome's pharmaceutical facility in Annan, Scotland. Terms under deal; Impact of impending purchase; Business activity at the site.

  • Shasun to Build Plant in U.S. Ramesh, Deepti // Chemical Week;2/4/2008, Vol. 170 Issue 4, p23 

    The article reports on the plan of pharmaceutical company Shasun Chemicals & Drugs Ltd. to establish a process development facility at Piscataway, New Jersey. The facility will provide direct active pharmaceutical ingredients (API) development services in the preclinical and clinical trial...

  • Shasun products in US, Europe.  // Chemical Business;Jun2005, Vol. 19 Issue 6, p78 

    Reports on the agreement of Shasun Chemicals & Drugs Ltd. with New Jersey-based Alpharma Inc. to market its genetic formulations in the U.S. and Europe. Terms of the agreement; Market size of the products in the regions.

  • Shasun bids for global status. Boswell, Clay // Chemical Market Reporter;1/16/2006, Vol. 269 Issue 2, p6 

    The article reports on the business developments of Shasun Chemicals & Drugs Ltd., a manufacturer of active pharmaceutical ingredients, excipients, generic drugs and formulations in Chennai, India. It mentions about the company's plan to acquire Rhodia Pharma Solutions and the company's...

  • Shasun inks deal with Alpharma.  // Chemical Market Reporter;6/6/2005, Vol. 267 Issue 23, p21 

    Reports that Chennai, India-based Shasun Chemicals and Drugs Ltd. continues to add to its roster of development and manufacturing alliances by signing a deal with the Fort Lee, New Jersey-based generic pharmaceutical company Alpharma Inc. Terms of the deal; Shasun's partnership with Glenmark...

  • ASIA.  // ICIS Chemical Business Americas;1/15/2007, Vol. 271 Issue 2, p14 

    The article presents news briefs on the chemical industry in Asia as of January 15, 2007. Shasun Chemicals & Drugs issued 2.25 million warrants which can be converted into shares. The joint venture company Pak-Iran Joint Investment is planning to establish refineries and petrochemical projects....

  • Asia Watch. Kovac, Matt // ICIS Chemical Business;1/15/2007, Vol. 2 Issue 49, p14 

    The article offers news briefs on the chemical industry in Asia. Chennai, India-based Shasun Chemicals & Drugs has decided to raise Rupees (Rs) 198 million through an issue of 2.25 million warrants at Rs88 each. The Pak-Iran Joint Investment Co. is focusing on naptha-based cracker projects that...

  • ChiRex opens R&D facility.  // Chemical Business;Jul96, Vol. 9 Issue 12, p78 

    Reports on Chirex's opening of a pilot plant center at its Dudley site in Great Britain.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics